Role of RelA and SpoT in Burkholderia pseudomallei virulence and immunity by Müller, CM et al.
  Published Ahead of Print 9 July 2012. 
2012, 80(9):3247. DOI: 10.1128/IAI.00178-12. Infect. Immun. 
E. Wand, Gregory J. Bancroft and Richard W. Titball
Claudia M. Müller, Laura Conejero, Natasha Spink, Matthew
 
pseudomallei Virulence and Immunity
Role of RelA and SpoT in Burkholderia
http://iai.asm.org/content/80/9/3247
Updated information and services can be found at: 
These include:
REFERENCES
http://iai.asm.org/content/80/9/3247#ref-list-1at: 
This article cites 49 articles, 26 of which can be accessed free
CONTENT ALERTS
 more»articles cite this article), 
Receive: RSS Feeds, eTOCs, free email alerts (when new
http://journals.asm.org/site/misc/reprints.xhtmlInformation about commercial reprint orders: 
http://journals.asm.org/site/subscriptions/To subscribe to to another ASM Journal go to: 
 o
n
 Septem
ber 1, 2014 by UNIVERSITY O
F EXETER
http://iai.asm
.org/
D
ow
nloaded from
 
 o
n
 Septem
ber 1, 2014 by UNIVERSITY O
F EXETER
http://iai.asm
.org/
D
ow
nloaded from
 
Role of RelA and SpoT in Burkholderia pseudomallei Virulence and
Immunity
Claudia M. Müller,a Laura Conejero,b Natasha Spink,b Matthew E. Wand,a* Gregory J. Bancroft,b and Richard W. Titballa
College of Life and Environmental Sciences, Biosciences, University of Exeter, Exeter, Devon, United Kingdom,a and London School of Hygiene and Tropical Medicine,
London, United Kingdomb
Burkholderia pseudomallei is a Gram-negative soil bacterium and the causative agent of melioidosis, a disease of humans and
animals. It is also listed as a category B bioterrorism threat agent by the U.S. Centers for Disease Control and Prevention, and
there is currently nomelioidosis vaccine available. Small modified nucleotides such as the hyperphosphorylated guanosine mol-
ecules ppGpp and pppGpp play an important role as signaling molecules in prokaryotes. They mediate a global stress response
under starvation conditions and have been implicated in the regulation of virulence and survival factors in many bacterial spe-
cies. In this study, we created a relA spoT double mutant in B. pseudomallei strain K96243, which lacks (p)ppGpp-synthesizing
enzymes, and investigated its phenotype in vitro and in vivo. The B. pseudomallei relA spoTmutant displayed a defect in sta-
tionary-phase survival and intracellular replication in murine macrophages. Moreover, the mutant was attenuated in theGalle-
ria mellonella insect model and in both acute and chronic mouse models of melioidosis. Vaccination of mice with therelA
spoTmutant resulted in partial protection against infection with wild-type B. pseudomallei. In summary, (p)ppGpp signaling
appears to represent an essential component of the regulatory network governing virulence gene expression and stress adapta-
tion in B. pseudomallei, and therelAspoTmutant may be a promising live-attenuated vaccine candidate.
Burkholderia pseudomallei, a Gram-negative, motile, aerobicbacterium of the class betaproteobacteria, is widely distrib-
uted throughout the biosphere and is the causative agent of the
life-threatening disease melioidosis (7). Infection with B. pseu-
domallei presents with a variety of nonspecific symptoms and can
range from acute disease, which is rapidly fatal, to chronic or
latent (i.e., asymptomatic) infections, which last for several de-
cades (9). Despite antibiotic treatment, mortality rates for acute
melioidosis can be 40 to 50% in areaswhere the disease is endemic,
and relapse rates in surviving individuals are also high [for a re-
view, see the work of Wiersinga et al. (48)]. Currently, there is no
vaccine, and therefore, B. pseudomallei is listed as a category B
select agent by the U.S. Centers for Disease Control and Preven-
tion.
Guanosine tetra- and pentaphosphates, collectively referred to
as ppGpp, are small signaling molecules that are produced in re-
sponse to various stress conditions such as amino acid starvation
[for reviews see the works of Cashel et al. (6), Magnusson et al.
(27), Potrykus andCashel (39), andDalebroux et al. (12)]. ppGpp
signaling is widespread across various genera of the bacterial king-
dom but can also be found in plant chloroplasts (4). The ppGpp
response has been extensively studied in Escherichia coli. In this
organism, stress-induced ppGpp interacts with theRNApolymer-
ase core enzyme and elicits a downregulation of ribosomal pro-
teins and DNA replication and an upregulation of amino acid
synthesis operons and genes involved in adaptation to stasis. This
so-called “stringent response”mechanism causes the bacterial cell
to stall growth and to redirect its resources to promote survival
mechanisms until nutrient conditions improve.
In many gammaproteobacteria, ppGpp is synthesized from
GTP and ATP by two enzymes, RelA and SpoT (see Fig. 1B). The
latter is a bifunctional enzyme that has both synthetase and hy-
drolase activities. Deletion of the spoT gene is lethal due to toxic
accumulation of ppGpp in the cell. On the other hand, deletion of
both the relA and spoT genes has a dramatic impact on gene ex-
pression profiles: microarray analyses of strains lacking ppGpp-
synthesizing enzymes have revealed deregulation of several hun-
dred genes (18, 34, 46), thereby highlighting the role of ppGpp as
a global signaling molecule.
The diverse phenotypes of ppGpp-deficient strains indicate
that this molecule affects various cellular processes, many in-
volved in survival and adaptation to stress conditions but also
others, such as sporulation, competence, quorum sensing, and
virulence [reviewed by Magnusson et al. (27), Braeken et al. (5),
and Dalebroux et al. (12)]. For example, in pathogenic bacteria
such as Francisella tularensis, Brucella spp., Campylobacter jejuni,
Legionella pneumophila, Helicobacter pylori, and Mycobacterium
tuberculosis, the absence of ppGpp-synthesizing enzymes results
in defects in stationary-phase survival, defects in intracellular rep-
lication, and attenuation in animal models of disease (10, 11, 16,
17, 21, 24, 41, 49).
In addition to their greatly reduced virulence, strains defective
in ppGpp synthesis have been shown to confer protective immu-
nity against challenge with wild-type bacteria. This is the case in
Salmonella enterica serovar Typhimurium (33), Salmonella en-
terica serovarGallinarum (37), Francisella tularensis (16), andYer-
sinia pestis (44). InY. pestis, protectionwas conferred via amixture
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of Th1 and Th2 immune responses, as measured by IgG1 and
IgG2a levels (44). In S. Typhimurium, the ppGpp mutant elicited
serum andmucosal antibody responses, measured by IgA and IgG
titers, as well as cellular immune responses, measured by a de-
layed-type hypersensitivity (DTH) response (33). Similarly, in S.
enterica, vaccination induced a B-cell response in bloodmeasured
by IgM, IgA, and IgG levels and induced CD4 and CD8 T-cell
proliferation and gamma interferon (IFN-) and transforming
growth factor (TGF)-4 production in spleens (37). This may
render ppGpp-deficient Salmonella strains promising candidates
as live-attenuated vaccines against typhoid in chicken.
Here, we evaluated a relA spoT double mutant of B. pseu-
domallei strain K96243 as a vaccine candidate. Live-attenuated
vaccines offer the advantage of containing complex epitopes, thus
stimulating both the antibody- and cell-mediated arms of the im-
mune system. This is of particular importance with facultative
intracellular pathogens such as B. pseudomallei. Moreover, live-
attenuated vaccines usually confer strong and long-lasting immu-
nity. Several live-attenuated vaccine strains of B. pseudomallei
have been tested to date [reviewed by Sarkar-Tyson and Titball
(42) and Patel et al. (38)]. Most of them are mutants with defects
in the intracellular life stages, such as mutations in biosynthetic
pathways or type III secretion systems. For example, the most
successful B. pseudomallei vaccine strain characterized to date,
strain 2D2, carries a mutation in the ilvI gene, which renders the
strain auxotrophic for the synthesis of branched-chain amino ac-
ids (3). However, none of the live-attenuated vaccine candidates
tested to date are able to confer sterilizing immunity or are able to
protect against chronic disease (38). This demonstrates the need
to assess whether different classes of mutants exhibit improved
protective efficacy.
Here, we targeted an important signaling system, namely, syn-
thesis of the alarmone ppGpp, for mutagenesis in B. pseudomallei.
We found that therelAspoT derivative was severely attenuated
in both acute and chronicmodels of disease, and subsequently, we
tested the ability of the mutant to confer protective immunity.
Our results from protection studies in mice indicated that this
mutant might be a medically relevant addition to the list of live-
attenuated vaccines against melioidosis.
MATERIALS AND METHODS
Bacterial strains and culture conditions.All strains and plasmids used in
this study are listed in Table 1. Unless stated otherwise, bacteria were
grown with aeration in Luria broth (LB) at 37°C. When required, the
antibiotics chloramphenicol (Sigma-Aldrich, Gillingham, United King-
dom), kanamycin (Sigma-Aldrich), and gentamicin (Sigma-Aldrich)
were used at concentrations of 25g/ml, 50g/ml, and 50g/ml, respec-
tively.
Mutant construction. In-frame deletion mutants were constructed
using a suicide plasmid containing regions homologous to up- and down-
stream regions of the target genes (26). Amplified DNA fragments used
for constructing the suicide plasmid derivatives were generated by recom-
binant PCR. Briefly, 600 bp up- and downstream fragments of the relA
(BPSL1946) and spoT (BPSL2561) genes of B. pseudomallei strain K96243
were PCR amplified using the primer combinations relA-1 and relA-2
(upstream), relA-3 and relA-4 (downstream), spoT-1 and spoT-2 (up-
stream), and spoT-3 and spoT-4 (downstream), respectively, and K96243
genomic DNA as a template. A second, recombinant PCR was performed
using the outside primers (relA-1 plus relA-4 and spoT-1 plus spoT-4)
and the respective up- and downstreamPCR fragments from the first PCR
as templates. The resulting 1.2-kb recombinant PCR products were
cloned into the suicide vector pDM4 via its XhoI/SphI and SalI/XmaI
sites, respectively. The presence of the recombinant PCR fragments in the
resulting plasmids pDM4-relA and pDM4-spoT was confirmed by
PCR using primer combinations relA-up plus relA-down and spoT-up
plus spoT-down, respectively. All plasmids were maintained in E. coli
DH5 pir cells. The sequences of all primers are listed in Table 2.
Biparentalmating.The pDM4derivativeswere introduced intoE. coli
strain S17 pir by electroporation. The resulting donor strains and the B.
pseudomallei recipient strains were grown overnight in LB medium at
37°C with aeration. One milliliter of the cultures was pelleted by centrif-
ugation, and the cells were resuspended in 0.5 ml fresh LB medium. Ten
microliters of these suspensions was transferred onto 1-cm by 1-cm
squares of nitrocellulose membrane (Hybond-ECL; GE Healthcare, Little
Chalfont, United Kingdom) placed on brain heart infusion (BHI; Fluka
Sigma-Aldrich) agar plates, either individually for control plates or with
donor and recipient together for the conjugations, and the plates were
incubated overnight at 37°C. The cells were scraped off the membranes
using sterile inoculation loops and transferred to tubes containing 1 ml
sterile PBS. One hundredmicroliters of these suspensions was plated onto
LB agar plates supplemented with gentamicin to select against the donor
strain and chloramphenicol to select for B. pseudomallei transconjugants
carrying the pDM4 constructs integrated into the chromosome.
TABLE 1 Strains and plasmids used in this study
Strain or plasmid Description Reference
B. pseudomallei strains
K96243 Clinical isolate from Thailand 23
K96243 relA Inactivation of BPSL1946 (relA) by complete deletion This study
K96243 relA spoT Inactivation of BPSL1946 (relA) and BPSL2561 (spoT) by complete deletion This study
576 Clinical isolate from Thailand 2
2D2 Auxotroph transposon mutant of B. pseudomallei 576 3
E. coli strains
DH5 pir recA1 gyrA (Nal) (lacIZYA-argF) (80dlac[lacZ]M15) pirRK6 43
S17-1 pir RPA-2 tra regulon; pirRK6 Smr Tpr 43
Plasmids
pDM4 Suicide vector with R6K origin; Cmr 29
pDM4-relA 600 bp up- and downstream of relA cloned into pDM4 via XhoI/SphI sites This study
pDM4-spoT 600 bp up- and downstream of spoT cloned into pDM4 via SalI/XmaI sites This study
Müller et al.
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Allelic exchange. The generation of clean in-frame deletion mutants
relied on a second recombination event, where the integrated pDM4 plas-
mid constructs were deleted from the chromosome by using sacB-medi-
ated counterselection. Overnight cultures of sacB transconjugants were
serially diluted in sterile PBS and plated onto salt-free LB agar plates
containing 10% (wt/vol) sucrose, which were incubated at 24°C for 2 to 3
days. Colonies obtained on these plates were tested for sensitivity to chlor-
amphenicol by patching themonto LB agar plates with andwithout chlor-
amphenicol. Chloramphenicol-sensitive colonies were analyzed for car-
rying a deletion of the target gene. Confirmation of the mutants was
performed by PCR using a primer that binds upstream of the fragment
used for mutagenesis (primer series 3) combined either with a reverse
primer that binds within the coding region of the target gene (primer
series 5), resulting in a PCR product only with wild-type cells, or with a
reverse primer that binds within the downstream region used for mu-
tagenesis (primer series 4), resulting in different-sized fragments with the
wild type anddeletionmutants.Mutantswere also confirmedby perform-
ing RT-PCR using the primer combinations relA-RT-1 plus relA-RT-2
and spoT-RT-1 plus spoT-RT-2, which specifically amplify the relA and
spoT transcripts, respectively, as described below.
The relA spoT double mutant was obtained by first deleting the relA
gene, followed by a second round ofmutagenesis deleting the spoT gene. A
spoT single mutant could not be obtained, despite several attempts.
RNA extractions. For transcriptional studies, bacteria were grown
aerobically at 37°C in LB broth overnight. Total RNA was extracted from
4.5 ml of these stationary-phase cultures using TRIzol reagent (Invitro-
gen, through Life Technologies, Paisley, United Kingdom) according to
the manufacturer’s recommendations. In brief, cells were harvested by
centrifugation at 12,000 rpm for 5min. Each cell pellet from1.5ml culture
was resuspended in 1ml TRIzol reagent. Cells were lysed by pipetting, and
samples were stored at80°C until they had passed a sterility check. Total
RNA was extracted after the addition of chloroform and precipitated in
isopropanol overnight at20°C. TheRNAwas pelleted by centrifugation,
washed with 70% ethanol, air dried for 5 min at room temperature, and
resuspended in nuclease-freewater. ContaminatingDNAwas removed by
DNase I (Ambion, through Life Technologies, Paisley, United Kingdom)
digestion for 45min at 37°C, followed by phenol-chloroform extractions,
isopropanol precipitation, and resuspension of the total RNA in nuclease-
free water as described above.
Semiquantitative RT-PCR. For cDNA synthesis, 4 g of total RNA
was mixed with 3 l of random primers at 3 g/l (Invitrogen) and 1 l
of a deoxynucleoside triphosphate (dNTP) mixture at 10 mM each (Pro-
mega, Southampton, United Kingdom). After primer annealing at 65°C
for 5 min, a mix of first-strand buffer, dithiothreitol (DTT), 40 U RNase
Out recombinant RNase inhibitor (Invitrogen), and 200U Superscript III
reverse transcriptase (Invitrogen) was added according to the manufac-
turer’s recommendations. cDNA synthesis was performed at 50°C for 60
min, followed by heat inactivation at 70°C for 15min. cDNA sampleswere
10	 diluted in water and directly used for PCR amplification. For the
adjustment of cDNA amounts, 16S rRNA was used as an internal stan-
dard, using primers 16S-RT-1 and 16S-RT-2. The sequences of all primers
are listed in Table 2.
Macrophage uptake and intracellular survival assays. Bacterial up-
take and survival inside macrophages were quantified using a modified
kanamycin protection assay as described previously (47). In summary,
J774A.1 murine macrophages were infected at a multiplicity of infection
(MOI) of 10 and incubated at 37°C for 2 h to allow bacterial internaliza-
tion to occur. Themediumwas then replacedwith freshmedium contain-
ing 250 g/ml kanamycin in order to suppress growth of extracellular
bacteria. At appropriate time points, cells were washed and lysed in 0.1%
(vol/vol) Triton X-100, and serial dilutions of the lysis mixture were
plated on LB agar plates for the determination of intracellular bacterial
numbers.
Galleriamellonella killing assays.Bacterial survival and virulence for
G. mellonella larvae were assessed by killing assays as described previously
(47). Briefly, 1	 104 CFU of bacteria in a volume of 10 l were injected
into the hemocoels of 10 larvae per bacterial strain. Larvae were incubated
statically at 37°C inside petri dishes, and the number of dead larvae was
TABLE 2 Oligonucleotides used in this study
Name Sequence (5=–3=)a Purpose
relA-1-fw CCCCTCGAGGAAGGCGCGCGGACAAGCGG Mutagenesis
relA-2-rv CGGCGCTCACTGCAGCATCGTCGGGTATGGCCAGTT Mutagenesis
relA-3-fw CCGACGATGCTGCAGTGAGCGCCGCCGGTGGGCCGC Mutagenesis
relA-4-rv CCCGCATGCCGTATCGACGAGTTCGCCGTC Mutagenesis
spoT-1-fw GCGGTCGACCTGCCGCCGTCGCTCGCGGC Mutagenesis
spoT-2-rv GCGGCGCTAACTAGTCATTTTCGCCTCCTGGGTTCG Mutagenesis
spoT-3-fw GCGAAAATGACTAGTTAGCGCCGCGCGGCGCCCGAC Mutagenesis
spoT-4-rv GCGCCCGGGGCCTGCGCGAAATCGAGGTCG Mutagenesis
relA-up-fw ACAACGGCACCGTCTATCTC Confirmation of plasmids
relA-down-rv GCGGTGTCATAACCGTATTC Confirmation of plasmids
spoT-up-fw CTCGCATTACCGTTGAAGAC Confirmation of plasmids
spoT-down-rv GCCCTTTCAGTTCGAAGTTG Confirmation of plasmids
relA-3-fw GCGTGCAGTCGGACCTGCTG Confirmation of mutation
relA-4-rv GTTCGGGAAAATTCGCAAGCC Confirmation of mutation
relA-5-wt GTGGAAGCGGAATCGGCTG Confirmation of mutation
spoT-3-fw GGTGAAGAAGCAGTTCCGCA Confirmation of mutation
spoT-4-rv CGCCCGAAACAAATGGCGG Confirmation of mutation
spoT-5-wt GCGGACGATGGTGTAGTGC Confirmation of mutation
relA-RT-1 AGATCCGCACGCAGGAAATG RT-PCR analysis
relA-RT-2 TTCGCTGTGCAGGTGGTAAG RT-PCR analysis
spoT-RT-1 GCGCATCAATGGCTCAAGTC RT-PCR analysis
spoT-RT-2 TTCAGGCGCATCGTCTTCAG RT-PCR analysis
16S-RT-1 GCCAGTCACCAATGCAGTTC RT-PCR normalization
16S-RT-2 ACCAAGGCGACGATCAGTAG RT-PCR normalization
a Restriction sites are underlined. Complementary regions are in italics. Translational start and stop codons are in bold.
Characterization of a B. pseudomallei relA spoT Mutant
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scored periodically. Intracellular bacterial numbers were determined 20 h
postinfection by draining the hemocoels of three larvae per strain and
plating serial dilutions onto LB agar plates.
Animal infection studies. Female C57BL/6 mice (6 to 8 weeks old;
Harlan Laboratories, Bicester, Oxon, United Kingdom) were used
throughout the studies. All animal experiments were performed in accor-
dance with the guidelines of the Animals (Scientific Procedures) Act of
1986 and were approved by the local ethical review committee at the
London School of Hygiene and Tropical Medicine. For each infection,
aliquots were thawed from frozen bacteria stocks and diluted in pyrogen-
free saline (PFS). Prior to intranasal infection, mice were anesthetized
intraperitoneally with ketamine (50 mg/kg; Ketaset; Fort Dodge Animal
Health, IA) and xylazine (10 mg/kg; Rompum; Bayer, Leverkusen, Ger-
many) diluted in PFS. Infection was performed by intranasally (i.n.) ad-
ministering a total volume of 50 l containing 2,500 CFU (acute model)
or 100 CFU (chronic model) of wild-type B. pseudomallei K96243 or the
isogenic relA spoT mutant. The infection dose was confirmed as de-
scribed elsewhere (22). Control uninfectedmice received 50l of PFS i.n.
Immunization studies. Female C57BL/6 mice were immunized i.n.
with 1	 105 CFU of B. pseudomallei 2D2 (3) or the relA spoTmutant
in a volume of 50 l. Sham-immunized mice received 50 l PFS. Five
weeks later they were challenged i.n. with 1	 103 CFU of B. pseudomallei
strain 576 in a volume of 50 l, and survival was monitored. On day 55
postinfection, survivors were culled and lungs and spleens aseptically re-
moved into cold PBS. Organs were homogenized through a 100-m cell
strainer (BD Falcon, CA), serial 10-fold dilutions of tissue homogenates
were plated onto tryptic soy agar plates (Sigma-Aldrich), and bacterial
colonies were counted after incubation for 24 to 48 h at 37°C. The limit of
detection was 50 CFU/organ.
Bright-fieldmicroscopy. Tenmicroliters of bacterial cultures was ap-
plied to coverslips placed inside the wells of a 24-well plate, and cells were
fixed using paraformaldehyde (4% in PBS) for 30 min. The coverslips
were washed three times in phosphate-buffered saline and inverted onto a
drop of Vectashield mounting medium (Vector Laboratories) on top of a
glass slide. The microscope slides were fumigated overnight before they
could be removed from the BSL3 suite. Samples were imaged at a magni-
fication of	100 using a Zeiss Axiophotmicroscope equippedwith VisiV-
iew software (Visitron Systems GmbH).
In silico analyses. Homologies between amino acid sequences were
determined using NCBI’s BLASTP algorithm. Conserved domains were
analyzed using NCBI’s conserved domain database (CDD). Promoter
predictions were performed using the Bprom software (Softberry).
Statistical analyses. Differences between average values were tested
for significance by performing an unpaired, two-sided Student’s t test. Log
rank tests of survival data were performed using the GraphPad Prism
software, version 5.01 (GraphPad Software, San Diego, CA). P values of
0.05 were considered significant.
RESULTS
RelA and SpoT proteins in B. pseudomallei. RelA and SpoT play
key roles in the generation of ppGpp in bacteria. The genome ofB.
pseudomallei strain K96243 was searched for homologues of the
RelA and SpoT proteins of Escherichia coli, which produced two
matches. BPSL1946 (predicted molecular mass 
 82.3 kDa) had
40% overall identity to RelAE.coli, whereas BPSL2561 (predicted
molecular mass 
 88 kDa) had 45% identity to SpoTE.coli. Inter-
estingly, no significant similarity was detected in the first 40 amino
acid residues of the N terminus of RelA of B. pseudomallei
(RelABps), whereas the start codon of SpoTBps seemed to be mis-
annotated by 59 amino acid residues. The identity between the
two paralogs was 34%, and both proteins were conserved in the
closely related species B. mallei and B. thailandensis. The B. pseu-
domallei proteins possess typical conserved domains for RelA-
SpoT-family proteins (28). No other RelA-SpoT-family proteins
were found in the genome by BLAST and PFAM searches. The
organization of the chromosomal regions surrounding the relA
and spoT genes, respectively, is depicted in Fig. 1A.
To further characterize the two proteins and the contribution
of ppGpp synthesis in B. pseudomallei, a relA single mutant and
a relA spoT double mutant were created in B. pseudomallei
strain K96243. The correct genotypes of the mutants were con-
firmed by PCR, and the absence of relA and/or spoT transcripts
was confirmed by reverse transcription-PCR (data not shown).
Since both genes are located at the end of putative transcriptional
units, no polar effects on downstream genes is expected (Fig. 1A).
A spoT single mutant could not be obtained despite several at-
tempts.
Stationary-phase survival is decreased inarelAspoTdou-
ble mutant of B. pseudomallei. As a first phenotypic test, the
growth of the mutants in axenic culture was analyzed. Both the
relA single mutant and a relA spoT double mutant grew at
rates similar to that of the wild type during exponential growth in
LB medium (Fig. 2A). Cultures of the relA spoT mutant
reached higher optical densities than cultures of the wild type and
the relA mutant at the transition into stationary phase between
12 and 24 h postinoculation, but the optical density decreased
steadily during the remainder of the experiment. The optical den-
sities of wild-type and relA mutant cultures remained at a con-
stant level throughout stationary growth phase and were found to
be twice as high as the values observed with the relA spoTmu-
tant on day 13. Despite the elevated optical density after 24 h
incubation, the number of CFU in cultures of the relA spoT
mutant was lower than in cultures of the wild type and the relA
single mutant (Fig. 2B), and numbers further decreased over time
until no viable bacteria could be detected at day 3 after inoculation
(Fig. 2B). In contrast, the number of viable cells remained con-
stant in cultures of the wild type for up to 1 week postinoculation
and decreased only marginally during the second week. The sur-
vival of the relA single mutant was more variable, with two of
four cultures exhibiting a decrease in the number of CFU over
time. However, on average, there was no significant difference
relative to the wild type (Fig. 2B). This indicates a severe defect in
stationary-phase survival only in the absence of both ppGpp-syn-
thesizing enzymes, similar to what has been described for other
organisms (21, 31, 41).
In keeping with this finding, early-stationary-growth-phase
cells of therelA single mutant did not appear to differ in size and
shape fromwild-type cells (Fig. 1C andD). In contrast, cells of the
relA spoTmutant appeared slightly bigger on average (Fig. 1E,
left) or had formed filaments of various lengths (Fig. 1E, right),
thereby indicating stress-related changes in cellmorphology in the
absence of both ppGpp-synthesizing enzymes.
ArelAspoTmutant of B. pseudomallei is unable to repli-
cate inside macrophages. B. pseudomallei is a facultative intracel-
lular organism that can survive inside macrophages. In order to
assess the intracellular survival ability of the relA and relA
spoTmutants, murine macrophages were infected with B. pseu-
domallei K96243 or isogenic mutants and the numbers of intra-
cellular bacteria were determined up to 10 h postinfection. While
the wild type exhibited intracellular replication over the course of
the experiment, the numbers of the relA spoT mutant did not
increase compared to the input (P 
 0.024 at 10 h postinfection
[p.i.]) (Fig. 3). The extent of bacterial uptake into phagocytic cells,
represented by the number of bacteria at 2 h after initial infection,
Müller et al.
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was not altered between the mutant and the wild type. The relA
single mutant exhibited an intermediate replication rate and no
significant difference in initial bacterial numbers. This suggests
that the presence of RelA-SpoT-family proteins is crucial for in-
tracellular survival in phagocytic cells.
ArelAspoTmutant ofB. pseudomallei is attenuated in an
insect model of infection. Previously, we demonstrated the value
of wax moth (G. mellonella) larvae as a model system to assess
virulence of B. pseudomallei isolates (47). Here, G. mellonella lar-
vae were infected with 1	 104 CFU of B. pseudomallei K96243 or
isogenic mutants, and survival of the larvae was monitored (Fig.
4A). Themedian survival time of larvae infectedwith thewild type
was 24 h, whereas infection with the relA mutant resulted in a
median survival time of 30 h (log rank test, P
 0.004). No larvae
infected with therelAspoT double mutant had died by the end
of 35 h (P
 0.002).When bacteria inside the larvae were enumer-
ated prior to the onset of paralysis at 20 h postinfection, a2,000-
fold increase in bacterial numbers compared to the input was
observed with the wild type (Fig. 4B). The growth rates of the
relA and relA spoT mutants were 2 times and 11 times lower
than that of wild type, respectively. This indicates a severe intra-
cellular growth defect and a significant attenuation in insect viru-
lence in the absence of RelA-SpoT-family proteins.
K96243 relA spoT is attenuated in murine models of in-
fection and is able to induce a protective immune response. To
further investigate the role of RelA and SpoT in virulence,
C57BL/6 mice were infected i.n. with B. pseudomallei K96243 or
therelAspoTdoublemutant at two different doses. A high dose
of 2,500 CFU of B. pseudomallei K96243 has been shown to result
in acute disease, with death of the mice occurring within 10 days
postinfection, whereas a lower dose of 1,000 CFU results in a
chronic infection (8). The relA spoT double mutant was atten-
uated in both the acute and the chronicmodel of infection, and all
mice survived for at least up to 70 days postinfection (Fig. 5A and
B). None of the mice infected with the B. pseudomallei relA
spoT mutant exhibited any outward signs of disease or weight
loss.
To test whether therelAspoTmutant is able to protect mice
from subsequent infection, C57BL/6 mice were immunized i.n.
with 1	 105CFUofK96243relAspoT orB. pseudomallei strain
2D2 as a positive control and challenged 5weeks later with 1	 103
CFU of B. pseudomallei strain 576 given i.n., which usually results
in an acute infection in naïve mice, with a time to death of 10
days postinfection. Immunization of mice with K96243 relA
spoT resulted in significantly increased survival of mice com-
pared to PFS control mice, with 100% survivors up to 30 days
FIG 1 Genetic organization and enzymatic activities of RelA-SpoT family proteins in B. pseudomallei and cell morphology of RelA-SpoT family mutants. (A)
Schematic overview of the chromosomal regions surrounding the relA gene (BPSL1946 [top]) and the spoT gene (BPSL2561 [bottom]). Predicted promoters and
their linear discriminant function (LDF) score are indicated. (B) Schematic of the classical synthesis pathway of (p)ppGpp. pppGpp is produced from GTP and
ATP by either RelA- or SpoT-dependent mechanisms and is subsequently converted to ppGpp. ppGpp interacts directly with the RNA polymerase enzyme
(RNAP) and thus affects gene expression. The effects of ppGpp induction are relieved by SpoT-mediated hydrolysis of ppGpp. (C to E) Cell morphology of B.
pseudomallei wild-type strain K96243 (C), a K96243 relA single mutant (D), and a K96243 relA spoT double mutant (E). All strains were grown to early
stationary growth phase (24-h incubation at 37°C) in LBbroth, and bacterial cells were visualized by bright-fieldmicroscopy at amagnification of	100. The scale
bars represent the average length of K96243 wild-type cells. In panel E, two images of K96243relAspoTmutant cells are presented, one focused on single cells
(left) and one focused on a filament (right).
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postchallenge (P 
 0.0061) (Fig. 5C). The pattern of survival of
the immunized animals was comparable to the pattern of survival
of mice that had been immunized with strain 2D2. Colonization
data of lungs and spleens of surviving animals that had been vac-
cinated with the K96243 relA spoT mutant showed undetect-
able CFU levels in three of five mice at day 55 after infection with
the wild type (Fig. 5D and E). However, bacteria could be detected
in the remainingmice, and one spleen sample exhibited extremely
large abscesses. This indicates that vaccination with arelAspoT
mutant of B. pseudomallei induces high levels of protective immu-
nity against B. pseudomallei infection, but as with all other live-
attenuated vaccines tested to date, sterile immunity was not
achieved.
DISCUSSION
In this study, we characterized the phenotype of a relA spoT
derivative of B. pseudomallei and have assessed its potential to
confer protective immunity on mice. Our results demonstrate
that RelA-SpoT-family proteins play an important role in survival
and virulence of B. pseudomallei and that a relA spoT mutant
may be a promising live-attenuated vaccine candidate.
The ppGpp-mediated stringent response is not well character-
ized in members of the betaproteobacteria. In phylogenetic anal-
yses, it has been shown that RelA and SpoT proteins of betapro-
teobacteria such as Bordetella spp. and Neisseria spp. cluster next
to the gammaproteobacterial branch (30). ppGpp production has
been described for Neisseria gonorrhoeae (20). In contrast to E.
coli, the gonococcal SpoT protein does not seem to contribute to
ppGpp production, and a relA single mutant had a growth defect
on rich solidmedium.TheB. pseudomalleiproteins share 45%and
44% identity with the RelA and SpoT proteins of N. gonorrhoeae,
respectively.
From our data, we propose that the stringent response in B.
pseudomalleimay be similar to the one observed in E. coli. First, we
were unable to create a spoT single mutant, which indicates that
SpoT is the only enzyme that can hydrolyze ppGpp in B. pseu-
domallei and thus prevent toxic accumulation. Moreover, the in-
termediate phenotype of the relA single mutant and its normal
growth rate indicate that SpoTBps also contributes to ppGpp syn-
thesis. Interestingly, as seen in Fig. 1A, SpoTBps is encoded up-
stream of the transcription elongation factor GreB, which also
FIG 2 Growth and stationary-phase survival of wild-type K96243 and iso-
genicmutants. All strainswere inoculated into LB broth at an optical density of
0.01, and cultures were incubated at 37°C with aeration. (A) Growth curve
representing the optical densities of the cultures at the indicated time points.
(B) Stationary-phase survival of the strains determined by plating samples
onto LB agar plates at the indicated time points. All experiments were per-
formed in at least three independent experiments, and data are plotted on a
logarithmic scale as means with standard deviations (A) or standard errors of
the means (B) for those experiments.
FIG 3 Intracellular survival of wild-type K96243 and isogenic mutants.
J774A.1 murine macrophages were infected with wild-type K96243 and iso-
genic mutants at an MOI of 10, and intracellular bacterial numbers were de-
termined at the indicated time points after initial infection by plating onto LB
agar plates. Bars and error bars represent themeans and standard deviations of
a representative experiment performed in three technical replicates for each
time point.
FIG 4 Killing of G. mellonella larvae by wild-type K96243 and isogenic mu-
tants. (A) Groups of 10 larvae per strain were injected with 1 	 104 CFU of
bacteria andmaintained at 37°C. Dead and live larvae were scored at indicated
time points and plotted as Kaplan-Meier survival curves. All curves were sig-
nificantly different from each other (log rank test; P  0.01 in all cases). (B)
The number of bacteria present inside the larvae at 20 h postinfection was
determined by aseptically removing the bottom 2mm of five larvae per strain,
draining the hemocoel, and plating serial dilutions onto LB agar plates. Results
are means and standard deviations from two independent experiments.
Müller et al.
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interacts with the RNA polymerase through the secondary chan-
nel (25), similarly to ppGppbutwith different effects (1, 40).More
detailed studies on the stringent response in B. pseudomallei could
provide a better understanding of survival and adaptability capac-
ities of this organism.
Here, we characterized the phenotype of a B. pseudomalleimu-
tant that is defective in RelA and SpoT enzymes, which are usually
involved in ppGpp synthesis and degradation. In other bacteria, it
has been shown that lack of ppGpp-synthesizing enzymes results
in defects in stationary-phase survival (21, 31, 41). Our results
show that this is also the case in B. pseudomallei. TherelAspoT
mutant had lost all viability after 3 days of incubation (Fig. 2B).
The viability of the relA single mutant seemed to be variable,
with some cultures having lost viability after 1 week, some exhib-
iting an initial decrease in CFU followed by a plateau at interme-
diate levels, and others showing no difference relative to the wild
type (data not shown), which might indicate the involvement of
suppressormutants or other stochastic effects, which remain to be
elucidated.
The assumed role of the ppGpp-mediated stringent response is
to reduce growth when cells encounter unfavorable growth con-
ditions, including nutrient deprivation upon entry into stationary
phase, and to redirect resources into adaptation and survival
mechanisms (27). In general, ppGppmutants seem to be unable to
modulate their growth rates and prepare for stationary-phase
survival. Stationary-phase adaptation includes morphological
changes such as a reduced cell size and rounding of cells (36). The
morphology of relA spoT mutant cells differed from that of
wild-type cells, as the mutant cells appeared slightly bigger on
average (compare Fig. 1C and E). This suggests that the relA
spoT mutant is unable to adopt a different morphology in re-
sponse to stationary-phase growth, whereas the filamentation in-
dicates that the bacteria experience stress, and we speculate that
these two effects might contribute to the reduced survival.
In this study, we assessed the virulence of relA and relA spoT
mutants in three different infectionmodels: amacrophage in vitro
model, an insect model, and mouse models of acute and chronic
melioidosis. The relA spoT double mutant was found to be
severely attenuated in all of the models, whereas the relA single
mutant exhibited intermediate levels of attenuation in the two
systems. Previously, we demonstrated the usefulness of the mac-
rophage model and the Galleria mellonella insect model for com-
paring the virulence of different Burkholderia isolates (47). The
results presented here demonstrate that either model can also be
used to assess the virulence of mutants, and in our case, the viru-
lence in the nonmammalian models reflected the virulence in
FIG 5 Survival and protection of mice infected with wild-type K96243 and its isogenic relA spoT mutant. (A and B) C57BL/6 mice were challenged
intranasally with an intended dose of 2,500 CFU (acute challenge [A]) or 500 CFU (chronic challenge [B]). Actual infection doses for each experiment are given
in parentheses. Log rank tests confirmed a significant difference in survival between the wild type and therelAspoTmutant in both cases (P 0.001 and P
0.05, respectively). (C to E)C57BL/6micewere immunized intranasallywith 1	 105CFUof strain 2D2orK96243relAspoT. After 5weeks of incubation,mice
were challenged intranasally with 1,000 CFU of B. pseudomallei strain 576. Mice were monitored for survival, and numbers are plotted as Kaplan-Meier survival
curves (C). Log rank tests confirmed a significant difference in survival of the K96243relAspoT and the 2D2 cohorts compared to the saline control (P 0.01
and P 0.05, respectively). At day 55 after infection with the wild type, bacterial burdens were assessed in lungs (D) and spleens (E) of survivors. Note that only
one mouse had survived up to this time point in the saline-treated sample group. The spleen of this mouse and that of one survivor in the K96243 relA spoT
sample group had extremely large abscesses and could not be harvested. N.A., not available.
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mice. Both model systems also provided further insights into the
possible mode of attenuation: mutants lacking ppGpp-synthesiz-
ing enzymes are attenuated not because of reduced bacterial up-
take or due to enhanced killing and clearance bymacrophages and
insect hemocytes but rather because of a defect in intracellular
replication (see bacterial numbers in Fig. 3 and 4B). The macro-
phage model may also prove useful to elucidate the role of ppGpp
in the intracellular lifestyle of B. pseudomallei in future studies.
In addition to being severely attenuated in mice, in both an
acute and a chronic model of disease, the K96243 relA spoT
double mutant also partially protected immunized animals from
intranasal challenge with virulent wild-type bacteria (Fig. 5C).
Pioneering studies by Dannenberg and Scott (13–15) had already
demonstrated the feasibility of immunization against experimen-
tal melioidosis using attenuated B. pseudomallei. However, the
genetic basis of attenuation of these strains is not known. More
recently, other workers assessed the feasibility of immunization
against experimental melioidosis using rationally attenuated B.
pseudomallei mutants. Immunization by the i.p. route, with a
range of mutants, has been shown to protect against acute disease
following a subsequent i.p. challengewithwild-typeB. pseudomal-
lei (35, 42). However, disease following an i.n. or inhalational
challenge is more severe than that seen following i.p. challenge
(45), and there are few studies which have demonstrated protec-
tion against an i.n. or inhalational challenge. In part, this might
reflect the finding that protection against an i.n. challenge appears
to be dependent on immunization by the same route (19). Immu-
nization of BALB/cmice i.n. with two doses of anasdmutant has
been shown to provide protection against acute disease following
a low-dose challenge (four 50% lethal doses), but deaths of chal-
lenged mice were recorded from day 15 postchallenge onwards
(35). A similar pattern of protectionwas observed after i.n. immu-
nization of BALB/cmice with an ilvImutant (2D2), after i.n. chal-
lenge with 1	 102 CFU of wild-type B. pseudomallei (19). How-
ever, these studies were carried out in BALB/c mice, and we
recently reported that the C57BL/6 infection model reflects the
spectrum of melioidosis seen in humans (8). Therefore, we con-
sidered that the C57BL/6 infection model would allow a more
meaningful assessment of the potential for live-attenuated mu-
tants to induce protective immunity in humans. In this study, we
report that C57BL/6 mice immunized i.n. with either 2D2 or the
relA spoT mutant of B. pseudomallei were protected against
acute disease following an i.n. challenge (1	 103 CFU) of B. pseu-
domallei strain 576, which has proven to provide a robustmeasure
of protection in many other vaccination studies. However, as in
previous studies, mice eventually succumbed to disease.
In addition to incomplete protection by B. pseudomallei live-
attenuated vaccines, concerns exist over their safety. The vaccine
strain, even though unable to cause overt disease, might persist in
the host and cause disease later in life. All our data indicate a defect
of the B. pseudomallei relA spoT mutant in long-term survival
in broth culture and in macrophages, but the strain has not been
tested for latency in vivo. Moreover, suppressor mutations of
ppGpp-deficient strains have been reported in E. coli, which abol-
ish their auxotrophy on minimal medium plates (6, 32, 50).
Therefore, more studies on the proneness to acquire suppressor
mutations and on the molecular mechanism of the intracellular
replication defect, including subcellular localization experiments,
have to be performed on the B. pseudomallei relA spoTmutant
before it can be considered safe. Nevertheless, identification of
different classes of protective vaccine strains may be useful for the
creation of a live-attenuated vaccine strain carrying a combination
of mutations, which could increase both protection and safety.
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